Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arch Biochem Biophys ; 401(2): 271-6, 2002 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-12054478

RESUMO

The human cyclin Bl gene is cell cycle regulated with maximal activity during G(2)/M. We examined the role of histone deacetylation in cyclin Bl regulation using the histone deacetylase inhibitor trichostatin A (TSA). TSA treatment (100 ng/ml) of NIH3T3 cells containing the luciferase reporter construct pCycB(-287)-LUC caused an increase in promoter activity in G(0) and G(1) but no significant change in G(2). Removal of upstream sequences including an E-box and Sp1 site eliminated the TSA induced increase in G(0) and G(1), and caused a decrease in promoter activity during S and G(2). Promoter activity increased only 2-fold following TSA treatment of G(0) cells containing the construct pCycB(MUT-E-Box)-LUC with an E-box mutation, and a decrease in activity was detected during G(2). We conclude that histone deacetylation contributes to the repression of cyclin B1 expression in G(0) and G(1), and that this mechanism requires, in part, the E-box. TSA reduction of cyclin B1 promoter activity in G(2), however, involves sequences within the first 119 bp. A working model for cyclin B1 regulation is provided.


Assuntos
Ciclo Celular/efeitos dos fármacos , Ciclo Celular/genética , Ciclina B/genética , Ácidos Hidroxâmicos/farmacologia , Células 3T3 , Acetilação , Animais , Ciclina B1 , Inibidores Enzimáticos/farmacologia , Fase G1/efeitos dos fármacos , Fase G1/genética , Fase G2/efeitos dos fármacos , Fase G2/genética , Genes Reguladores/efeitos dos fármacos , Inibidores de Histona Desacetilases , Histonas/química , Histonas/metabolismo , Humanos , Camundongos , Modelos Biológicos , Mutação , Regiões Promotoras Genéticas/efeitos dos fármacos , Fase de Repouso do Ciclo Celular/efeitos dos fármacos , Fase de Repouso do Ciclo Celular/genética , Fase S/efeitos dos fármacos , Fase S/genética , Regulação para Cima/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA